More information about ADVAXIS INC.

Advaxis is a biotechnology company developing immunotherapies that enlist the body’s own immune system to fight cancer. We discover, develop and make better medicines through innovative sciences. Advaxis’ proprietary Lm targeted immunotherapy is a new approach toward aneffective cancer vaccine. Our Lm Technology has achieved safety and efficacy endpoints in early-stage trials and is the platform for our continued focus on the science,discovery,development and commercialization of cutting-edge cancer treatments.